Provided by Tiger Trade Technology Pte. Ltd.

Pyxis Oncology, Inc.

1.99
-0.0200-1.00%
Post-market: 1.990.0038+0.19%19:30 EDT
Volume:1.10M
Turnover:2.14M
Market Cap:236.98M
PE:-1.42
High:2.03
Open:2.03
Low:1.90
Close:2.01
52wk High:5.55
52wk Low:1.03
Shares:119.08M
Float Shares:108.42M
Volume Ratio:0.65
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4029
EPS(LYR):-1.2813
ROE:-179.10%
ROA:-62.95%
PB:20.71
PE(LYR):-1.55

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Pyxis Oncology (PYXS) and Candel Therapeutics (CADL)

TIPRANKS
·
May 15

Pyxis Oncology Faces Urgent Capital Needs and Potential Dilution Risks Amid Market Volatility

TIPRANKS
·
May 15

Pyxis Oncology Shares Slide on Steeper 1Q Loss

Dow Jones
·
May 15

Pyxis Oncology Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Pyxis Oncologyreports Q1 EPS (37c), consensus (35c)

TIPRANKS
·
May 14

Pyxis Oncology Q1 EPS $(0.37), Inline

Benzinga Earnings
·
May 14

Pyxis Oncology Q1 Net Income USD -23.272 Million

Reuters
·
May 14

Pyxis Oncology Q1 net loss widens on higher clinical trial costs

Reuters
·
May 14

Pyxis Oncology Q1 Income From Operations USD -24.36 Million

THOMSON REUTERS
·
May 14

Pyxis Oncology Q1 EPS USD -0.37

THOMSON REUTERS
·
May 14

Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances Micvo Toward Key 2026 Clinical Milestones

THOMSON REUTERS
·
May 14

Press Release: Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Dow Jones
·
May 14

Pyxis Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 13

Creative Global Technology Holdings And 2 Other Promising Penny Stocks

Simply Wall St.
·
May 12

Pyxis Oncology Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
May 11

Pyxis Oncology appoints Nelson Azoulay chief business officer

Reuters
·
May 08

Pyxis Oncology Initiated at Outperform by Wedbush

Dow Jones
·
May 05

Wedbush bullish on Pyxis Oncology, initiates with an Outperform

TIPRANKS
·
May 05

Wedbush Initiates Pyxis Oncology at Outperform With $6 Price Target

MT Newswires Live
·
May 05

Pyxis Oncology Inc : Wedbush Initiates Coverage With Outperform Rating; Target Price $6

THOMSON REUTERS
·
May 05